Dapagliflozin, Sitagliptin & Metformin HCl (ER) Tablets – TESARIL DM SR

Dapagliflozin, Sitagliptin & Metformin HCl (ER) Tablets – For the approach to diabetes management.

TESARIL DM SR: The Triple composition of Sitagliptin 100mg + Dapagliflozin 10mg + Metformin 500mg (SR) Tablets offers a multifaceted approach to managing type 2 diabetes, effectively addressing various mechanisms involved in glucose regulation. Sitagliptin, a DPP-4 inhibitor that enhances incretin hormones to improve glycemic control, alongside Dapagliflozin, an SGLT2 inhibitor that facilitates glucose elimination through urine, and Metformin, which lowers blood sugar levels by decreasing liver glucose production and improving insulin action.

Recommended By Specialists:
 Diabetologists: It is preferred to treat he disease associated with multi-drug oral therapy for T2DM
 General Physicians: It is recommended for the treatment of the disease-associated maintenance therapy in stable diabetic patients

Key Benefits of Dapagliflozin, Sitagliptin & Metformin HCl (ER) Tablets – TESARIL DM SR:
 Synergistic Mechanism of Action: Combines the DPP-4 inhibition of Sitagliptin, which increases incretin levels to boost insulin secretion and lower glucagon levels, with Dapagliflozin’s SGLT2 inhibition that promotes renal glucose excretion and Metformin’s ability to enhance insulin sensitivity and reduce hepatic glucose production.
 Holistic Glycemic Management: Effectively targets both fasting and postprandial glucose levels, providing a robust solution for comprehensive diabetes control.
 Convenient Single Tablet Dosing: This combination allows for once-daily dosing, simplifying the treatment regimen and improving patient adherence to therapy.

INDICATIONS:
 Type 2 Diabetes Mellitus
 Inadequate glycemic control
 Monotherapy resistance